Vaccine

SINOVAC Biotech is urging shareholders to vote against proposals to replace the board, citing its efforts to restore shareholder value, including dividend payments and a strategic realignment. The company launched www.VoteSinovac.com and filed an investor presentation with the SEC, highlighting the board’s commitment to maximize shareholder investment, defend against litigation from a dissenting investor group, and potentially relist on the Hong Kong Stock Exchange.